Scientists

Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.

SNMMI 2017 Annual Meeting

Make your plans to attend the SNMMI 2017 Annual Meeting—the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. SNMMI's marquee event provides you with an in-depth view of the latest technologies and research in the field.

Download A Preview BrochureBook Your Hotel | View Sessions | Register Online


Networking and Special Programming

The SNMMI Annual Meeting also offers special targeted programming, and great opportunities for you to reconnect with your peers from around the globe, including:

*Additional fee applies

Coding and Reimbursement

The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.

For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.

For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.

Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!

Dose Optimization

In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.

SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.

 

Preclinical Imaging

The goal of the SNMMI Best Practices in Preclinical Imaging Initiative is to provide guidelines based on the community experience in designing and conducting preclinical imaging experiments.

Available Resources Include:

Focusing on the Future of Molecular Imaging

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.

Access resources.

The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.

Educational Offerings

SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors. 

Visit the SNMMI Learning Center.


Additional Resources

  • March 20, 2017SNMMI Social Media Reach Engagement Milestones

    Today, information is received through a variety of media. What social media excels at is providing immediacy and a network of colleagues. It’s evident that these channels provide valuable information, as SNMMI’s Facebook page now has more than 12,000 likes, and the SNMMI LinkedIn group has more than 11,000 members!
    (SNMMI News)

  • March 15, 2017In Memoriam: Dirk (Dik) J. Kwekkeboom, MD, PhD

    Dirk (Dik) J. Kwekkeboom, MD, PhD, professor of nuclear medicine at Erasmus Univeristy in Rotterdam, The Netherlands, passed away March 8, 2017. An SNMMI member since 1998, he was considered one of Europe’s foremost experts on peptide receptor radiotherapy and was a frequent international speaker on neuroendocrine tumor imaging and lutetium-177 octreotate therapy. 
    (Member News)

  • March 13, 2017New in JNMT

    The March 2017 issue of "The Journal of Nuclear Medicine Technology" is now available.
    (SNMMI News)

  • March 6, 2017Fluciclovine PET/CT Improves Radiotherapy Targeting for Recurrent Prostate Cancer

    The featured clinical investigation article of the March 2017 issue of "The Journal of Nuclear Medicine" demonstrates that the PET radiotracer fluciclovine (fluorine-18; F-18) can help guide and monitor targeted treatment for recurrent prostate cancer, allowing for individualized, targeted therapy.
    (Press Release)

Spotlight

Guidelines

The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.

View Guidelines.

Featured Resources

  • 2014 NCI-SNMMI Workshop on Targeted Radionuclide Therapy

    The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the National Cancer Institute (NCI) held a joint workshop—NCI-SNMMI Workshop on Targeted Radionuclide Therapy—on October 24-25, 2014, at the National Institutes of Health (NIH) in Bethesda, Md.

  • Guidance

    Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.

  • Legislative Issues

    SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis.

  • Journals

    Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.

  • Nuclear Medicine and Molecular Imaging Week: October 2-8, 2016

    Happy Nuclear Medicine Week! Encourage community members to take pride in their profession – recognizing their colleagues for their hard work and promoting nuclear medicine to the entire medical community as well as to the public.